Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation.
Hsiehchen D, Elliott A, Xiu J, Seeber A, El-Deiry W, Antonarakis ES, Graff SL, Hall MJ, Borghaei H, Hoon DSB, Liu SV, Ma PC, McKay RR, Wise-Draper T, Marshall J, Sledge GW, Spetzler D, Zhu H.
Hsiehchen D, et al. Among authors: ma pc.
Cancer Cell. 2024 Nov 13:S1535-6108(24)00405-7. doi: 10.1016/j.ccell.2024.10.017. Online ahead of print.
Cancer Cell. 2024.
PMID: 39577419